Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
17.9%
% of PBE's 28 holdings also in IBRN
11.9%
% of IBRN's 60 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE | Weight in IBRN | Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 5.0% | 4.2% | 4.2% |
|
BIOGEN IDEC INC | 5.0% | 3.9% | 3.9% |
|
CATALYST PHARMACEUTICAL PART | 3.3% | 4.7% | 3.3% |
|
PTC THERAPEUTICS INC | 3.0% | 4.4% | 3.0% |
|
ACADIA PHARMACEUTICALS INC | 2.5% | 4.1% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBRN
|
GILEAD SCIENCES INC | 5.1% |
|
AMGEN INC | 5.0% |
|
NATERA INC | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.5% |
|
UNITED THERAPEUTICS CORP | 4.4% |
|
ILLUMINA INC | 4.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.9% |
|
TG THERAPEUTICS INC | 3.8% |
|
HALOZYME THERAPEUTICS INC | 3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
PBE Underweight Relative to IBRN
|
INTRA-CELLULAR THERAPIES INC | -4.2% |
 |
ARGENX SE ADR | -4.2% |
 |
ALKERMES PLC | -4.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.9% |
|
DENALI THERAPEUTICS INC. | -3.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
EDGEWISE THERAPEUTICS, INC. | -3.3% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
SAREPTA THERAPEUTICS INC | -2.9% |